Modeling patients’ time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants

por Leminen, Aapeli, Pyykönen, Mikko, Tynkkynen, Juho, Tykkyläinen, Markku, Laatikainen, Tiina
Publicado 2019

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin

por Pyykönen, Mikko, Linna, Miika, Tykkyläinen, Markku, Delmelle, Eric, Laatikainen, Tiina
Publicado 2021